Helen Rubinstein | Director of Investor Relations |
Barry Greene | Chief Executive Officer |
Jim Doherty | Chief Development Officer |
Chris Benecchi | Chief Business Officer |
Kimi Iguchi | Chief Financial Officer |
Laura Gault | Chief Medical Officer |
Anupam Rama | JPMorgan |
Ritu Baral | PD Cowen |
Yasmeen Rahimi | Piper Sandler |
Jay Olson | Oppenheimer |
Paul Matteis | Stifel |
Sumant Kulkarni | Canaccord |
Neena Bitritto-Garg | Citi |
Tim Lugo | William Blair |
Marc Goodman | SVB Securities |
Good morning. Welcome to the Sage Therapeutics' First Quarter 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode. This call is being webcast live on the Investors and Media section of Sage's website at sagerx.com. This call is the property of Sage Therapeutics and recording, reproduction, or transmission of this call without the expressed written consent of Sage Therapeutics is strictly prohibited.